IgG4-RD is a chronic inflammatory condition that can affect multiple organs at a time. It is an immune-mediated disease that may lead to fibrosis (scarring of tissues).
Swelling of salivary glands
Lower back pain
Fatigue
Abdominal pain
Eye pain
Weight loss
IgG4-RD can impact people in many different ways. People may have IgG4-RD for months or even years before a diagnosis is confirmed. This can result in organ damage before the individual is even aware. IgG4-RD is diagnosed by different specialties as the condition affects multiple different organs. Therefore, a combination of tests and findings is required for a diagnosis of IgG4-RD.
Treatments options for IgG4-RD include:
IgG4-RD is a rare disease that requires more effective treatment options as there are currently no approved therapies specifically for IgG4-RD. In order to find these new treatments for IgG4-RD, further research is necessary.
Current Research Studies
There are over 15 research studies actively recruiting participants with IgG4-RD. Visit ClinicalTrials.gov to find IgG4-RD research studies near you.
Artiva's AlloNK® Study for scleroderma aims to understand whether an investigational natural killer (NK) cell therapy can help reduce your scleroderma symptoms.
Artiva's AlloNK® Study for Sjögren’s aims to reduce inflammation and symptoms of Sjögren’s.
If you have Sjögren’s, you may be eligible for the Resolve Sjögren’s study, which is evaluating if a study drug may reduce fatigue, dryness in the eyes and mouth, and joint pain in women with Sjögren’s.
Find an online community of fellow patients, caregivers, and advocates below as
as well as some other general resources!